Companies: 10,795·Total market cap: $144.5T
NewGenIvf Group Limited

NewGenIvf Group Limited

NIVFNASDAQHealthcare● Active
$0.55
$-0.09(-14.51%)
Market Cap$310031
P/E Ratio
52W High$618
52W Low$0.51
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

NewGenIvf Group Limited (NIVF) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001981662 · NIVF · NASDAQ · as of Jun 9, 2026

Filing snapshot

148
Total Filings
4
Latest Form
2026-06-08
Most Recent
2022
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001981662 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-03-31
Fiscal Year End
Mar 31, 2026
Accession No.
0001213900-26-037687
Primary Document
ea0283766-20f_newgenivf.htm
Source: data.sec.gov · CIK 0001981662 · Accession 0001213900-26-037687

Latest Key Filings

6-KQuarterly Report
REPORT OF FOREIGN PRIVATE ISSUER
2026-06-04
8-KCurrent Report
8-K12B
2024-04-03Material Event
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-06-08
View
3Initial Statement of Beneficial Ownership
PRIMARY DOCUMENT
2026-06-04
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-06-04
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-28
View
3Initial Statement of Beneficial Ownership
PRIMARY DOCUMENT
2026-05-27
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-21
View
RWRW
WITHDRAWAL REQUEST
2026-05-12
View
20-FAnnual Report (Foreign Issuer)
ANNUAL REPORT
2026-03-31
View
3Initial Statement of Beneficial Ownership
OWNERSHIP DOCUMENT
2026-03-31
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-27
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-27
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-27
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-24
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-23
View
EFFECTEFFECT
EFFECT
2026-03-13
View
Showing 1–15 of 140 filingsForm 4 / 144 hidden· 148 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001981662  |  Exchange: NASDAQ · Healthcare

NewGenIvf Group Limited (NASDAQ: NIVF) has submitted 148 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2022. As a Healthcare sector company with CIK 0001981662, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is NewGenIvf Group Limited's most comprehensive regulatory disclosure. The most recent NewGenIvf Group Limited 10-K was filed on 2026-03-31 for fiscal year ending 2026. Historical NIVF 10-K annual reports are available from 2023 through 2026.

Investors researching NewGenIvf Group Limited SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09

Frequently Asked Questions

NIVF SEC Filings · 8 questions

NewGenIvf Group Limited (NIVF) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 148 filings and access original documents at no cost. NewGenIvf Group Limited's CIK is 0001981662.

NIVF SEC filingsNewGenIvf Group Limited SEC documentsfind NIVF 10-K